Table 1.
Study population | NonSEV group (n = 19) | SEV group (n = 24) | p value | |
---|---|---|---|---|
Male | 30 | 12 | 18 | – |
Female | 13 | 7 | 6 | – |
BMI (kg/m2) | 28.44 ± 5.53 | 28.50 ± 5.42 | 28.37 ± 5.83 | 0.91 |
Duration of (min) | ||||
Anaesthesia | 282 ± 68 | 291 ± 79 | 275 ± 60 | 0.59 |
Surgery | 222 ± 65 | 235 ± 74 | 212 ± 60 | 0.23 |
CPB | 112 ± 59 | 124 ± 74 | 103 ± 45 | 0.54 |
AC | 70 ± 39 | 74 ± 44 | 66 ± 36 | 0.56 |
BMI body mass index, AC aorta clamping, CPB cardiopulmonary bypass, SEV sevoflurane. NonSEV group patients who were anesthetised intravenously, SEV group patients who were anesthetised intravenously and received SEV inhalation before CPB